Anaplastic Pleomorphic Xanthoastrocytoma

Anaplastic Pleomorphic Xanthoastrocytoma — Trials · CancerIndex

Clinical trials

Registered studies

6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 67%
Top sponsor: Jazz Pharmaceuticals
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04541082	Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms	recruiting	Phase 1	102	Jazz PharmaceuticalsINDUSTRY	1	Dec 18, 2025	clinicaltrials
NCT03434262	SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors	completed	Phase 1	68	St. Jude Children's Research HospitalOTHER	1	May 31, 2024